Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1029) clinical trials

This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.

Phase

The rrAD study is testing several strategies that may reduce the risk of Alzheimer’s disease in individuals at risk for the disease when compared to usual care. These strategies include: Aerobic exercise Intensive medical management of blood pressure and cholesterol The combination of these two approaches

Phase

This is a study for early to mild Alzheimer’s, testing the safety of LY3002813 with or without LY3202626 and any side effects from the study medicine. This study is also evaluating whether LY3002813 with or without LY3202626 can help slow the mental and functional changes of Alzheimer’s disease.

Phase

This study is being done to see whether an investigational drug called LY3303560 is safe and tolerable and whether it might work to help people with Alzheimer’s disease. “Investigational” means that the drug being tested has not been approved for routine clinical use or for the use described in this ...

Phase

A research study is evaluating an investigational medication to see if it might improve cognitive ability, including attention, memory, and language in patients who have dementia with Lewy bodies (DLB).

Phase N/A

A research study is evaluating an investigational medication for symptoms of agitation and irritability associated with Alzheimer’s Disease.

Phase N/A

A research study is evaluating an investigational medication for early symptoms of Alzheimer’s Disease.

Phase N/A

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Phase

Do something unforgettable today. Take part in research to help prevent Alzheimer’s.  

Phase